Advisors Asset Management’s Inspire Medical Systems INSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.12K Sell
182
-14
-7% -$664 ﹤0.01% 1366
2026
Q1
$10.1K Hold
196
﹤0.01% 1387
2025
Q4
$18.1K Sell
196
-4
-2% -$383 ﹤0.01% 1357
2025
Q3
$14.8K Buy
200
+43
+27% +$4.35K ﹤0.01% 1374
2025
Q2
$20.4K Sell
157
-2,069
-93% -$300K ﹤0.01% 1340
2025
Q1
$355K Sell
2,226
-48
-2% -$8.68K 0.01% 1003
2024
Q4
$422K Sell
2,274
-133
-6% -$25.8K 0.01% 966
2024
Q3
$508K Sell
2,407
-2,476
-51% -$430K 0.01% 926
2024
Q2
$653K Buy
4,883
+62
+1% +$11.7K 0.01% 831
2024
Q1
$1.04M Sell
4,821
-57
-1% -$11.2K 0.02% 732
2023
Q4
$992K Buy
4,878
+759
+18% +$123K 0.02% 725
2023
Q3
$817K Buy
4,119
+876
+27% +$221K 0.02% 767
2023
Q2
$1.05M Buy
+3,243
New +$927K 0.02% 712

Other funds holding INSP

Advisors Asset Management's INSP Position: Q2 2026 in Review

Advisors Asset Management reduced its Inspire Medical Systems (INSP) stake by 7.1% in Q2 2026, selling an estimated $664 and leaving 182 shares worth $8.12K. The position accounts for ﹤0.01% of the portfolio, ranked #1366.

Advisors Asset Management first reported a position in INSP in Q2 2023 and has held it in 13 quarters since. The position peaked at $1.05M in Q2 2023. 276 funds tracked by Wall St. Rank hold INSP as of Q2 2026.

  • Advisors Asset Management held 182 shares of Inspire Medical Systems worth $8.12K as of Q2 2026.
  • Advisors Asset Management sold 14 Inspire Medical Systems shares in Q2 2026, an estimated $664.
  • Inspire Medical Systems made up ﹤0.01% of Advisors Asset Management's portfolio in Q2 2026, its #1366 holding.
  • Advisors Asset Management first reported a position in Inspire Medical Systems in Q2 2023 and has held it in 13 quarters since.
  • Advisors Asset Management's Inspire Medical Systems position peaked at $1.05M in Q2 2023.
  • 276 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q2 2026.

Based on Advisors Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.